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In a  previous study, methylenedioxypyrovalerone (MDPV), a  designer drug of the cathinone family, caused selective enhancement 
of Caspase3 immunoreactive (Casp3+) apoptotic cells in the nucleus accumbens (NAc) of 7‑day‑old mice. To further elaborate on 
the mechanism underlying MDPV‑elicited apoptosis, here, we investigated the appearance of Casp3+ cells in developing neural tube 
explants of E12.5 mice, following MDPV treatment in vitro. Apoptotic cells appeared in large number in the pallium as radial progenitor 
cells and multipolar neurons, and in the subpallium including the future NAc, both in control and MDPV treated specimens. MDPV 
did not cause gross morphological changes in the neural tube or in the abundance of Casp3+ cells, based on a visual impression, 
though quantification was not attempted. We also studied the changes in NMDA receptor (NMDAR) protein subunits NR1 and NR2B 
in the NAc of 7‑day‑old MDPV treated and control mice, using western blotting of tissue obtained by selective dissection. In MDPV 
treated animals, expression of NR2B was lower than in the control animals, whereas expression of NR1 did not differ significantly from 
controls. The findings indicate that, during early postembryonic development, downregulation of the NR2B receptor subunit (at this 
time predominant in the NMDAR) is accompanied by a decreased viability of neurons. Decreased viability is expressed, in this case, as 
enhanced susceptibility to stimulation by MDPV – essentially a robust dopaminergic agent, potently affecting the neurons of the NAc. 
The findings are likely relevant to dopaminergic/NMDAR interactions and a potential pro‑survival role of the NR2B subunit in critical 
phases of neural development.
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INTRODUCTION
Synthetic cathinones belong to the group of the 
so‑called novel psychoactive substances (NPS) also 
known as ‘designer drugs’. One member of the family, 
methylenedioxypyrovalerone (MDPV), is a frequently 
used psychoactive drug of abuse. In a previous study 
(Ádám et al., 2014), we found a marked increase in 
the number of apoptotic cells in the piriform cortex, 
retrosplenial area, hippocampus CA1 and nucleus ac‑
cumbens (NAc), without an overall change of cell den‑
sity, in 7‑day‑old mice (developmentally comparable to 
the human fetus of the third trimester). Apoptosis in 
C57BL/6J mice 24 hours after i.p. injection of 10 mg/kg 
body weight of MDPV or vehicle (saline) was estimat‑
ed by anti‑caspase 3 (Casp3) immunohistochemistry 
and cell counting. The greatest percentage of increase 
in apoptotic cells was observed in the NAc. However, 
MDPV did not seem to increase apoptosis in adult mice 
(Ádám et al., 2014). Based on these observations, the 
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mechanism of action appears to be developmentally 
determined. 
The objective of the present study was to further 
elaborate on the factors and potential mechanisms 
underlying the apoptotic effect of MDPV. First, we ad‑
dressed the question whether the boost of apoptosis 
observed as a result of postnatal MDPV administration 
could also be demonstrated in the embryonic brain. In 
a previous study, we reported that gestational exposure 
of pregnant mice to this cathinone in a critical period 
between E7 and E14 was followed by subtle locomotor 
dysfunction in the offspring (Gerecsei et al., 2018). This 
observation raised the possibility of a definite, if by no 
means destructive, interaction of MDPV with the de‑
veloping brain. The present study attempts to address 
this issue further by investigating the effect of direct 
exposure of the neural tube to MDPV, potentially inter‑
fering with programmed cell loss in the course of early 
development of the neural tube.
Secondly, given the conspicuously high incidence 
of apoptosis evoked by MDPV in the NAc, specifical‑
ly implicated in reward and addiction, the neurode‑
generation elicited by the drug is likely related to its 
emotional and rewarding effects. One of the candidate 
targets are N‑methyl‑D‑aspartate receptors (NMDAR) 
which are known to undergo developmental alteration 
(maturation) and also display functional plasticity. 
We, therefore, investigated the alterations of NMDAR 
subunit distribution by measuring the expression lev‑
els of receptor proteins in the NAc of 7‑day‑old mice, 
24 hours after systemic bolus administration of MDPV.
A plausible mechanistic link between NMDARs and 
the action of MDPV is the neurotransmitter dopamine. 
Like other members of the cathinone family, or cocaine 
and methamphetamine, MDPV is known to exert its 
effect mainly via dopaminergic activation. A potent 
blocker of the dopamine transporter and norepineph‑
rine transporter, with a weaker effect on serotonin up‑
take (Baumann et al., 2013b), MDPV induces an outward 
current, similar to, but longer lasting than cocaine 
(Cameron et al., 2013). MDPV is a dose‑dependent re‑
inforcer in a continuous self‑administration schedule 
(Watterson et al., 2014), also evoking stereotypies, el‑
evating heart rate, blood pressure and core body tem‑
perature (Marusich et al., 2012; Baumann et al., 2013a, 
Fantegrossi et al., 2013).  
Here, we examined whether alterations in NMDAR 
subunit expression could also play a role in the apopto‑
sis evoked by MDPV. Given the age‑dependent shifting 
of heteromeric NMDARs known as the NR2B to NR2A 
switch (Gray et al., 2011), and, correspondingly, an ex‑
pected low level of NR2A in the mouse pups at 7 days 
of age, we used the expression of NR2B together with 
NR1, as a general marker of overall NMDAR expression. 
Prima facie it was expected that an enhanced propor‑
tion of NR2B in the assembly of the NMDAR tetramer 
would lead to diminished survival of the affected neu‑
ronal progenitors. It is well‑established that extrasyn‑
aptic (perisynaptic) NMDARs, which become activated 
mainly by an overflow of glutamate from the synaptic 
cleft domain, consist of NR1 and NR2B subunits (Momi‑
yama, 2000). Activation of extrasynaptic receptors has 
been known to cause neuronal death by shutting off 
the pro‑survival CREB pathway and inactivating ERK 
and its downstream signaling partners (Hardingham 
et al., 2002). However, at certain developmental stages 
and receptor locations, NR2B can also play a pro‑sur‑
vival role (Martel et al., 2009). Thus, determining the 
direction of change in the NMDAR composition follow‑
ing exposure to cathinone drugs may have important 
consequences and warrants investigation. 
METHODS
Animals
BALB/c mice were mated in the animal facility of 
the Department of Anatomy, Histology and Embryology. 
Pregnant females were housed individually under stan‑
dard laboratory conditions (12 hours dark/12 hours 
light cycle) with food and water available ad libitum. 
Seven pregnant dams were used for the NMDA recep‑
tor analysis, and a further 2 for obtaining neural tube 
explants (see below). From the 7 litters altogether 50 
pups were obtained, from which 3 individuals were 
used for preliminary testing and optimizing protein 
yield. The pups were randomly selected for control and 
MDPV treatment from each litter in near‑equal num‑
bers. A total of 47 samples from the NAc (left and right 
hemispheres combined) were used for NR2B analysis, 
whereas, for NR1 the final number of pooled samples 
was 12 (6 controls and 6 MDPV treated samples). Once 
born, the pups were kept together with the mothers 
until they had reached day 7 of age. Then, a total of 
25 animals of either sex from each litter (5‑10 pups/
litter), were treated with 10 mg/kg MDPV i.p. (diluted 
in saline), while the rest (22) of the animals received 
saline only. The dose was selected on the basis of our 
preliminary behavioral observations in adult mice: it 
caused visible alteration of behavior (increased loco‑
motor activity, stereotypies) without lethal conse‑
quences. It also corresponded to the MDPV concen‑
tration applied in previous experiments (Ádám et al., 
2014), bringing about enhanced locomotor activity and 
apoptotic cell death in several brain regions, particu‑
larly the NAc, of 7‑day‑old mice. Following treatment, 
the pups remained with the dams until they were sacri‑
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ficed 24 hours after the injection. For embryonic treat‑
ments, BALB/c (white) laboratory mice with timed 
pregnancy were purchased from the National Institute 
for Oncology, Budapest. 
The experiments were conducted in conformity 
with the laws and regulations controlling experiments 
and procedures in live animals, as described in the 
Principles of Laboratory Animal Care (NIH Publication 
85‑23, revised 1985). Our Department is in possession of 
a valid experimental license for working with labora‑
tory animals including mice, issued by the Food Chain 
Safety and Animal Health Directorate of the Govern‑
ment Office for Pest County, Hungary (license number: 
XIV‑I‑001‑2269‑4/2012).
Chemicals
The racemic mix of MDPV used was the product of 
LGC Standards (Teddington, Middlesex, UK) and pur‑
chased through Medinspect Kft (Fót, Hungary). The 
experiments were carried out under a special license 
(#27924/2011/KÁB) issued by the Narcotic Drugs Con‑
trol Department, Office of Health Authorization and 
Administrative Procedures, Hungary.
Western blot analysis of NMDA receptor protein 
subunits
Immediately after decapitation of the animals, the 
brains were removed and dissected into coronal slabs 
with the help of a brain mold. The slabs from the appro‑
priate coordinates were placed on top of a black pow‑
der‑coated aluminum box containing ice. Tissue sam‑
ples of the NAc were dissected bilaterally under a ste‑
reomicroscope. The diagram in Fig. 1A shows the rostral 
facet of the cut slab with the approximate borders of 
dissection. The removed tissue block contained major 
parts of the NAc (practically the whole core and most 
of the shell), together with fragments of the adjacent 
septum, bed nucleus of stria terminalis and the anteri‑
or commissure. Given the small brain size of 7‑day‑old 
pups, most of the NAc samples weighed less than 10 mg. 
This presented a technical difficulty in immunoblotting, 
especially in the case of the anti‑NR1 antibody of lesser 
detection sensitivity. Therefore, we had to use pooled 
samples for quantification of NR1. For NR2B detection 
and quantification, the original protein values were suf‑
ficient (except for 5 samples which had to be eliminated 
because the final protein concentration of the lysate fell 
below the limit of detectability), whereas, NR2A proved 
to be below the detection level in this age group (see 
above). Nevertheless, the gain in tissue specificity (sam‑
ples centered on the NAc) far outweighed the loss in the 
protein available for Western blot.
The dissected brain specimens (the combined bilat‑
eral samples counted as one) were immediately placed 
into plastic vials and stored in dry ice until further pro‑
cedures. The specimens were homogenized in ice‑cold 
lysis buffer (150 mM NaCl; 1% Nonidet P‑40; 0.5% sodium 
deoxycholate; 0.1% sodium dodecyl sulfate, SDS; 50 mM 
Tris, pH 8.0). Due to the low weight, samples were pooled 
in the case of NR1 level measurement. To separate the 
cellular debris from total protein content, centrifuga‑
tion at 4°C, 1,200 g for 10 minutes followed. The super‑
natant was centrifuged again at 15,000 g for 10 minutes 
at 4°C. The sediment contained the crude synaptosome 
fraction. Protein concentrations in the brain homoge‑
nates were determined using the BCA method (Olson 
and Markwell 2007). Samples were dissolved in Laemmli 
buffer (Sigma‑Aldrich) and heated at 96°C for 5 min‑
utes. Then, all samples were diluted to an even con‑
centration (1 μg/μl). Samples containing 10 or 20 μg of 
total protein (for NR2B or NR1, respectively) were load‑
ed onto 8% acrylamide gels and processed with BioRad 
Mini‑Protean III vertical electrophoresis and blotting 
systems. Proteins were separated by SDS‑polyacryl‑
amide gel electrophoresis (PAGE) and electrophoreti‑
cally transferred to nitrocellulose membranes. Then, 
the membranes were immediately incubated with 1% 
skimmed milk (Cell Signaling) in TBS‑T buffer (0.05 M 
Tris‑buffered saline pH 7.4 and 0.1% Triton X) for 1 hour 
at room temperature. The membranes were incubated 
with anti‑NR1 (diluted at 1:1000), anti‑NR2B (diluted at 
1:2000) or anti‑β‑actin (1:100,000) primary antibodies 
(Cell Signaling, rabbit) overnight at 4°C. After washing, 
HRP conjugated anti‑rabbit secondary antibody (DAKO, 
1:20,000) was added to the NMDA receptor samples, and 
HRP conjugated anti‑mouse secondary antibody (DAKO, 
1:10,000) to the beta‑actin samples. The blots were visu‑
alized and quantified with an enhanced chemilumines‑
cence detection system (BioRAD) and standardized by 
the luminosity of the housekeeping protein beta‑actin 
using ImageLab software.
MDPV exposure of E12.5 mouse neural  
tube explants 
Details of the technique have been previously re‑
ported (Echevarría et al., 2001). Briefly, the uterine 
horns of pregnant dams were removed and immedi‑
ately placed in ice‑cold buffer (PBS) solution until fur‑
ther dissection. The embryos were individually dis‑
sected from the amniotic sac, the heads were cut off 
at the level of rhombomere 2 and the neural tube was 
exposed by careful removal of the epidermis and mes‑
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enchyme, with the help of a binocular stereomicro‑
scope. Whole mouse telencephalic vesicles including 
the striatal region, were dissected from E12.5 mouse 
embryos and incubated in 24‑well tissue culture plates 
(in 400 µl/well) with 4% fetal bovine serum in Neu‑
robasal culture medium with supplement of B‑27plus 
and Penicillin‑Streptomycin (100 U/ml – 100 µg/ml; 
Thermo Fisher Scientific). Cultures were maintained 
for 24 hours in an incubator at 37°C, with 5% CO2 and 
95% humidity. To study the effect of drug, 0.1 mg/ml 
of MDPV (n=5), or 1.0 mg/ml of MDPV (n=5) was added 
to the incubation medium, whereas 6 specimens con‑
tained no added drug (control). Following incubation, 
the specimens were fixed by immersion in 4% buffered 
paraformaldehyde for 2 hours, washed in PBS, im‑
mersed in 10% and 20% sucrose and frozen. From the 
tissue blocks, 10‑20 µm thick sections were cut with 
a cryostat, transferred onto glass slides and allowed 
to dry.
Immunostaining for activated Caspase‑3
For immunohistochemistry, the sections were in‑
cubated in a moist chamber under droplets of the fol‑
lowing solutions. The sections were washed in 0.1 M 
PB (4‑10 minutes) and pretreated with pepsin solution 
for antigen retrieval (0.1 mg/ml pepsin with 1 N HCl in 
dist. H2O), followed by a blocking solution of 5% normal 
goat serum (NGS; in 0.1 M PB for 30 minutes at room 
temperature). Then, the sections were incubated with 
a polyclonal rabbit anti‑Casp3 antibody (Sigma‑Al‑
drich; 1:1000, in PBS containing 1% NGS and 0.3% Tri‑
ton X‑100) for 48 hours at 4‑8°C. After rinsing in 0.1 M 
PB (3 x 20 minutes), the sections were incubated with 
Alexa Fluor 488 associated anti‑rabbit IgG (Molecu‑
lar Probes; 1:250, in 0.1 M PB) for 3.5 hours at room 
temperature. Sections were mounted in PBS‑glycerol 
1:1 and viewed and photographed with an Olympus 
BX 50 fluorescent microscope equipped with a digital 
camera. Immunostaining of the postembryonic speci‑
mens was carried out on free‑floating frozen sections, 
as reported previously (Ádám et al., 2014). Selected 
sections were counterstained for 30 minutes at room 
temperature with the nuclear marker fluorochrome 
4,6‑diamidino‑2‑phenylindole dihydrochloride (DAPI) 
(Sigma‑Aldrich), 5 mg/ml in PBS. 
RESULTS
Similar to the previously reported study (Ádám et 
al., 2014), a considerable number of Casp3+ apoptotic 
cells were observed after MDPV treatment of 7‑day‑old 
neonatal mice, amounting to 1‑2% of all cells (as de‑
tected by DAPI counterstaining) in most forebrain re‑
gions, e.g. the striatum (Fig. 1B). A specific enrichment 
of apoptotic cells in the NAc has already been reported 
in detail in the cited study (Ádám et al., 2014), and is not 
shown here. Casp3+ immunoreactivity clearly marked 
the outlines of cells of neuronal morphology, although 
the bulk of the label was accumulated in the nuclear 
and perikaryal regions (Fig. 1C). The morphological 
Fig.  1. (A) Diagrammatic representation of the dissection of nucleus ac‑
cumbens specimens removed for western blotting. The rostral facet of the 
coronal brain slab, corresponding to the matching coronal Image 41 of the 
mouse from the Allen Brain Atlas (http: //atlas.brain‑map.org), is shown. 
The position of the NAc, its surrounding regions and their proportions to 
the whole sectional area correspond well to those observed in a P7 mouse. 
The frame marks the approximate outlines of the tissue sample. Ac – an‑
terior commissure, CP – caudate‑putamen, Ctx – cortex, NAc – nucleus ac‑
cumbens. (B‑C) Representative fluorescent microscopic images depicting 
two apoptotic (Casp3+) neurons (arrows) against the background of DAPI 
labelled nuclei in the striatum of a PD7 mouse, 24 hours after treatment 
with a single i.p. injection of MDPV. (B) Combined image. (C) Single channel 
image, for the better demonstration of the slightly varicose processes of 
bipolar‑looking (presumably progenitor) neurons. Scale bar: 50 µm.
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features of apoptotic cells are well discernible also in 
embryonic brain specimens (Fig. 2A), clearly marking 
bipolar progenitor cells as well as multipolar neurons 
in certain regions of the pallium of the telencephalon 
(Fig. 2B). Following treatment with MDPV, the over‑
all structure of the neural tube appeared normal. and 
Casp3+ neural elements were abundant both in pallial 
and subpallial (including the prospective NAc) regions 
(Fig. 2C). Control specimens (without MDPV treat‑
ment) gave a very similar qualitative impression to 
those from MDPV treated neural tubes (Fig. 2D‑E), both 
containing a large number of overlapping Casp+ cells. 
Thus, the embryonic study suggested that MDPV treat‑
ment did not affect the gross morphology of the neu‑
ral tube, nor did it visibly alter the physiological cell 
loss in the course of early neurogenesis and migration. 
Next, we turned to the question of whether drug treat‑
ment at the age of 7 days, known to elicit a robust in‑
crease in apoptotic cells in the NAc (Ádám et al., 2014), 
would also alter the subunit composition of NMDARs in 
the same brain region. As detected by western blotting 
of NMDAR protein components (Fig. 3A‑C), the expres‑
sion of NR2B subunits in the MDPV‑treated group was 
significantly decreased (F3,34=8.36, P=0.043). Converse‑
ly, the expression of NR1 subunits was not significant‑
ly altered (F10=1.47, P=0.253) (Fig. 3C), i.e. an overall 
downregulation of NMDA receptors in total is not sup‑
ported by the findings. However, lacking firm data on 
Fig. 2. (A‑E) Representative fluorescent microscopic images of the forebrain region of the E12.5 mouse neural tube, directly exposed to 1 mg/ml MDPV in 
organotypic culture medium for 24 hours, demonstrating the distribution of apoptotic (Casp3+) cells. (A) Overview in sagittal section. (B) An enlarged view 
of the frame over the pallium shows the types of Casp+ bipolar neural progenitors (arrows) nearer the pial surface and multipolar neurons in the juxtaven‑
tricular layer (dashed arrows). (C) Abundance and distribution of apoptotic (Casp3+) cells in pallial. subpallial and diencephalic regions. (D) Representative 
image of the pallium of a control neural tube. (E) Representative image of the pallium of an MDPV treated neural tube. On (D) and (E) the surface directed 
toward the telencephalo‑diencephalic border is marked by asterisks, whereas, the juxtaventricular surface is marked by bold arrows. Some Casp+ cell 
bodies are indicated by arrowheads. Note the similar density and overlapping of labeled cells and their processes in these regions of control and MDPV 
treated pallia. cf – cephalic flexure, lv – lateral ventricle, Hy – hypothalamus, NAc – nucleus accumbens (septostriatal transition area), OB – olfactory bulb, 
Pall – pallium, POA – preoptic area, Sept – septum, Thal – thalamus. Scale bars: 200 µm (A, C), 50 µm (B, D, E).
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the NR2A receptor subunit, a selective downregulation 
of NR2B would require further confirmation. 
DISCUSSION
The cathinone drug MDPV has been reported to 
cause selective enhancement of Casp3+ (apoptotic) 
cells in certain limbic forebrain regions, in particular, 
the NAc of 7‑day‑old (but not of adult) mice (Ádám et 
al., 2014). That this neurodegenerative effect, evoked 
by a bolus injection of the drug to young neonatal mice, 
might have something to do with a dopaminergic surge 
(also responsible for other rewarding and addictive ef‑
fects), has been supported by additional findings on 
prenatal animals. Chronic MDPV administration during 
pregnancy resulted in increased locomotor activity of 
7‑ and 21‑day‑old pups, also causing an impairment 
of maternal care, however, the latter could not be ex‑
plained by changes in two relevant hypothalamic pep‑
tides (TIP39 and amylin). Thus, the observed anomalies 
were likely associated with agitated behavior and neg‑
ligence due to the (mainly dopaminergic) psychoactive 
drug (Gerecsei et al., 2018). 
In the current study, while confirming the presence 
of apoptotic (Casp3+) cells of distinctly neuronal mor‑
phology in the striatum of 7‑day‑old neonatal mice, 
we also attempted to investigate if there was a direct 
neurodegenerative effect of MDPV in the course of the 
early development of the neural tube. Apoptotic cells 
appeared in large number already at postnatal day 
(PD) 12‑13 in mouse embryonic brain explants, both in 
pallial zones (radial cells and multipolar neurons) and 
in the developing subpallium including the future NAc. 
Such an abundance of Casp3+ cells did not make it pos‑
sible to evaluate a direct effect of MDPV on embryonic 
brain explants since any subtle changes brought about 
by MDPV treatment would have been masked by the 
massive surge of apoptosis in control specimens. How‑
ever, it did suggest that MDPV did not affect the gross 
morphology of the neural tube or alter the physiolog‑
ical cell loss in the course of early neurogenesis and 
migration. This period corresponds to the first wave 
of apoptosis (Blaschke et al., 1998), where the surge of 
apoptotic cells in the embryonic brain precedes the 
phase of synaptogenesis in the mouse (notably, in hu‑
mans, the period of synaptogenesis sets in well before 
birth, in the third trimester of gestation). In prenatal 
Fig. 3. Abundance and distribution of NMDAR subunit proteins determined by quantitative western blotting from selective mouse brain samples enriched 
in the nucleus accumbens, as a function of treatment with MDPV. (A) Representative immunoblot images of NR1 at 110 kDa. The pockets marked by (#) 
represent control (saline‑treated animals), whereas, those marked by (+) represent MDPV treated animals. (B) Representative immunoblot images of NR2B 
at 180 kDa visible above those of the housekeeping protein beta‑actin at 42 kDa. The pockets marked by (#) represent control (saline‑treated animals), 
whereas those marked by (+) represent MDPV treated animals. (C) Diagrams of optical density values (normalized by actin) for NR2B and NR1 receptor 
subunit proteins. The columns show the mean + S.E.M. The values of n for NR1: n=6, 6 (for MDPV and control, respectively), and those for NR2B: n=21, 21 
(for MDPV and control, respectively). The asterisk represents a statistically significant difference p<0.05.
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mice, the amount of Casp3+ cells were found to peak at 
E14.5 (Renier et al., 2014), i.e. quite close to the period 
of our current study. Such robust apoptosis in the em‑
bryonic brain, amounting to 50 percent of total cells 
in rodents (Blanquie et al., 2017) may sound surpris‑
ing and certainly is not yet fully understood. However, 
programmed cell death most likely subserves the se‑
lection of the appropriate clones of neurons. Further‑
more, activity patterns strongly determine the fate 
(survival or apoptosis) of maturing neurons, as report‑
ed for cortical areas of early neonatal mice (Blanquie 
et al., 2017).
Expression of activated Casp3, representing the sec‑
ond surge of apoptosis (Southwell et al., 2012; Nikolić 
et al., 2013), can also be observed in the intact postem‑
bryonic brain as an indicator of physiological cell loss. 
In the mouse primary motor and somatosensory cor‑
tices, the density of apoptotic cells (as revealed by 
Casp3 immunostaining) was found to peak between PD 
4 and PD 7, the upper cortical layers (I‑IV) displaying 
the highest values (Blanquie et al., 2017). Apoptotic 
(Casp3+) cells were found to be particularly abundant 
in the NAc of 4‑day‑old mice, as compared to other re‑
gions of the basal forebrain (bed nucleus of the stria 
terminalis, caudate‑putamen), only exceeded by the 
medial preoptic area (Broad et al., 2009). Mice have 
been found to be susceptible also to the apoptotic neu‑
rodegeneration induced by ethanol, at the end of the 
first postnatal week (the synaptogenesis period) (Olney 
et al., 2002). 
Based both on the proposed molecular (dopami‑
nergic) mechanism and on the observed age depen‑
dence of the drug effect, it was reasonable to assume 
that the neurodegenerative action of MDPV is likely 
related, at least in part, to alterations in NMDAR sub‑
unit composition. 
The subunit composition of heteromeric NMDARs 
undergoes dynamic changes during pre‑ and postnatal 
development of rodents. The most important postnatal 
change is known as the NR2B to NR2A switch, as a re‑
sult of which part of the former subunit will get grad‑
ually replaced by the latter (Gray et al., 2011). In a de‑
tailed study from postsynaptic density (PSD) enriched 
hippocampal samples of postnatal mice, the NR2B/
NR2A ratio was found to be over 1.5 at day 7, just under 
1.0 at day 14 and ca. 0.8 at day 28, with a further slow 
decrease till day 56 (Sinclair et al., 2016). This change 
is due mainly to a robust increase in the abundance 
of GluN2A, whereas, GluN2B remains largely stable 
(Sinclair et al., 2016). The NMDARs containing the sub‑
unit 2B participate mainly in neurogenetic signaling, 
in particular, the development and potentiation of syn‑
apses (El Gaamouch et al., 2012), even in the wiring of 
adult‑born neurons of the olfactory bulb (Kelsch et al., 
2012). Those NMDARs harboring the subunit 2A will be 
operational in synaptic transmission, e.g. the genera‑
tion of excitatory postsynaptic current (EPSC). Howev‑
er, there is evidence to suggest that, even in the adult 
brain, both NR2A and NR2B can be present and func‑
tionally active concurrently, in particular in the NAc 
(Chergui, 2011). Although recent studies have revealed 
an increasing contribution of triheteromeric NMDARs, 
containing two NR1 subunits alongside one NR2A and 
one NR2B (Zamzow et al., 2013; Stroebel et al., 2018), or 
NMDARs with other NR2 subunit forms (C and D), the 
reported percentage of the 2A or 2B subunits among 
functional NMDARs in the NAc was at least 30‑34% or 
46‑57%, respectively (Chergui, 2011). Moreover, NR2A 
and NR2B proved to be the only GluN2 subunits to ac‑
count for the NMDAR‑EPSCs in the CA1 of the hippo‑
campus (Gray et al., 2011).
The findings indicate that under conditions of ear‑
ly postembryonic development, downregulation of the 
NR2B receptor subunit (at this time the main com‑
ponent of the functional NMDA receptor tetramer) is 
accompanied by decreased viability of neurons (simi‑
lar to the observation on rat forebrain culture – Fu et 
al., 2011). In adults (by which time the NR2A subunit 
becomes predominant in the functional NMDA recep‑
tor) no such consequence was seen (Ádám et al., 2014). 
Decreased viability was expressed, in our case, as en‑
hanced susceptibility to stimulation by MDPV – essen‑
tially a robust dopaminergic agent, predominantly af‑
fecting the neurons of the NAc. Potential interaction 
between dopamine and NMDA receptors may be due 
(as described in an elegant study by Liu et al., 2006) 
to a direct association between the dopamine D2 re‑
ceptor and the NR2B receptors (specifically responsive 
to cocaine), in the postsynaptic microdomain of a cer‑
tain category (striatopallidal) of striatal/NAc medium 
spiny neurons. On powerful dopaminergic stimulation 
(which occurs with a number of psychostimulatory ad‑
dictive drugs, including MDPV) this D2R‑NR2B inter‑
action may lead to an inhibition of NMDAR (via D2R 
dependent reduction of CaMKII activity and NMDA 
phosphorylation) and the suppression of the indirect 
striatal pathway, leading to hypermotility (see a re‑
cent study by Giannotti et al., 2017). Selective vulner‑
ability of striatal neurons to neurotoxic damage due 
to methamphetamine exposure (ultimately evoked by 
excess dopamine) has been reported previously (Zhu 
et al., 2006; Tulloch et al., 2011).
Activation of the extrasynaptic (perisynaptic) 
NMDARs, predominantly consisting of NR1 and NR2B 
subunits, is known to cause neuronal death by shutting 
down of the pro‑survival CREB pathway and inactivat‑
ing ERK and its downstream signaling partners (Hard‑
ingham et al., 2002). However, in certain developmental 
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stages and receptor location, NR2B can play a pro‑sur‑
vival role as well (Martel et al., 2009). As evidenced by 
the present observation, this may well be the case with 
neonatal mice at the peak of the second apoptotic surge 
and before the completion of synaptogenesis.
Apart from dopaminergic/NMDAR interactions, 
other molecular mechanisms evoked by MDPV and po‑
tentially causing cell death should also be taken into 
consideration. A single exposure to MDPV and 1‑phe‑
nyl‑2‑(pyrrolidin‑1‑yl)pentan‑1‑one (α‑PVP) has been 
reported to change the baseline neuronal activity (ex‑
pression of the immediate early genes c‑Fos and Arc/
Arg 3.1 mRNA), both in the striatum and in the hip‑
pocampus of mice (Giannotti et al., 2017). Survival of 
embryonic brain cells may depend on baseline activity 
(Blanquie et al., 2017). Moreover, a potential link be‑
tween cathinone (methylone and MDPV) induced apop‑
tosis and autophagy in human dopaminergic cells has 
also been reported (Valente et al., 2017).
CONCLUSIONS
Apoptotic (Casp3+) cells had appeared in large num‑
ber already at E12.5 in mouse brain explants, both in 
pallial zones (as radial cells and multipolar neurons) 
and in the subpallium including the future NAc. In vi-
tro treatment with the cathinone drug MDPV (0.1 or 
1 mg/ml) failed to alter the morphology of the neural 
tube. Massive overproduction of Casp3+ cells in the 
control brain did not allow evaluation of a direct effect 
of MDPV on embryonic brain explants. 
As a potential molecular mechanism, we studied the 
alterations of NMDA receptor protein subunits NR1 and 
NR2B in 7‑day‑old MDPV treated and control mice, us‑
ing western blotting from selectively dissected brain 
samples enriched in the NAc. In MDPV treated animals, 
the level of NR2B was significantly lower than in con‑
trol animals, whereas NR1 was not significantly differ‑
ent from controls (i.e. an overall decrease of NMDA re‑
ceptor expression is unlikely).
The findings indicate that under conditions of early 
postnatal development, downregulation of the NR2B re‑
ceptor subunit (at this time the main component of the 
functional NMDA receptor tetramer) is accompanied by 
decreased viability of neurons, which is expressed, in 
our case, as enhanced susceptibility to stimulation by 
MDPV – essentially a robust dopaminergic agent, pre‑
dominantly affecting the neurons of the NAc as a main 
reward center. 
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